Showing 85 to 96 of 213 results
NHS DEI Initiatives Criticized for Misguided Approaches, Racial Health Disparities Highlighted
UK Health Secretary Wes Streeting criticized the NHS's diversity, equality, and inclusion (DEI) initiatives for misguided approaches such as "anti-whiteness", citing racial health disparities (Black men twice as likely to die from prostate cancer, Black women three times more likely to die in childb...
NHS DEI Initiatives Criticized for Misguided Approaches, Racial Health Disparities Highlighted
UK Health Secretary Wes Streeting criticized the NHS's diversity, equality, and inclusion (DEI) initiatives for misguided approaches such as "anti-whiteness", citing racial health disparities (Black men twice as likely to die from prostate cancer, Black women three times more likely to die in childb...
Progress
60% Bias Score
Half a Million Cancer Patients in England Faced Excessive Treatment Delays
Analysis of NHS figures reveals that 506,335 cancer patients in England waited over two months for treatment in the last decade, with significant variations across cancer types, leading to concerns about preventable deaths due to treatment delays.
Half a Million Cancer Patients in England Faced Excessive Treatment Delays
Analysis of NHS figures reveals that 506,335 cancer patients in England waited over two months for treatment in the last decade, with significant variations across cancer types, leading to concerns about preventable deaths due to treatment delays.
Progress
48% Bias Score
NHS Opens First Teen Vaping Clinic in England
The NHS launched England's first teen vaping cessation clinic at Alder Hey in Liverpool in January 2025 to combat rising youth vaping rates (18% of 11-18 year olds vaped in 2024), offering tailored treatments and collecting data to improve future interventions.
NHS Opens First Teen Vaping Clinic in England
The NHS launched England's first teen vaping cessation clinic at Alder Hey in Liverpool in January 2025 to combat rising youth vaping rates (18% of 11-18 year olds vaped in 2024), offering tailored treatments and collecting data to improve future interventions.
Progress
40% Bias Score
NHS England Prioritizes Shorter Waiting Times, Scrapping Preventative Healthcare Plans
NHS England is scrapping plans to improve early cancer diagnosis, women's health, and childhood vaccinations, prioritizing shorter waiting times for A&E, cancer care, and hospital treatment to address public concerns about long delays, despite criticism from health experts and charities.
NHS England Prioritizes Shorter Waiting Times, Scrapping Preventative Healthcare Plans
NHS England is scrapping plans to improve early cancer diagnosis, women's health, and childhood vaccinations, prioritizing shorter waiting times for A&E, cancer care, and hospital treatment to address public concerns about long delays, despite criticism from health experts and charities.
Progress
48% Bias Score
High Costs of Private Hysterectomies Expose NHS Gynaecological Care Delays
Research by the Royal College of Obstetricians and Gynaecologists reveals that British women are paying up to £11,154 for private hysterectomies due to significant delays in NHS gynaecological care, with three women sharing their experiences of seeking private treatment.
High Costs of Private Hysterectomies Expose NHS Gynaecological Care Delays
Research by the Royal College of Obstetricians and Gynaecologists reveals that British women are paying up to £11,154 for private hysterectomies due to significant delays in NHS gynaecological care, with three women sharing their experiences of seeking private treatment.
Progress
44% Bias Score
Welsh GPs Accept Improved Pay Deal
The BMA Cymru Wales accepted a revised pay deal from the Welsh government, granting a 6% pay rise to GPs and all practice staff, along with a £23 million practice stabilisation payment, addressing concerns about insufficient funding and improving patient data collection.
Welsh GPs Accept Improved Pay Deal
The BMA Cymru Wales accepted a revised pay deal from the Welsh government, granting a 6% pay rise to GPs and all practice staff, along with a £23 million practice stabilisation payment, addressing concerns about insufficient funding and improving patient data collection.
Progress
24% Bias Score
Cancer Specialist's Diagnosis Highlights Advancements and Challenges in NHS Cancer Care
Professor Adrian Crellin, a 70-year-old cancer specialist, was diagnosed with prostate cancer in 2016 and is receiving treatment at the Bexley Wing in Leeds, highlighting the emotional challenges and advancements in NHS cancer care; prostate cancer cases in England increased by 25% since 2019.
Cancer Specialist's Diagnosis Highlights Advancements and Challenges in NHS Cancer Care
Professor Adrian Crellin, a 70-year-old cancer specialist, was diagnosed with prostate cancer in 2016 and is receiving treatment at the Bexley Wing in Leeds, highlighting the emotional challenges and advancements in NHS cancer care; prostate cancer cases in England increased by 25% since 2019.
Progress
40% Bias Score
Eight-Hour A&E Wait for Heart Attack Patient Highlights NHS Delays
68-year-old Steven Richardson endured an eight-hour wait at Worcestershire Royal Hospital's A&E department after a heart attack on November 30th, due to ambulance handover delays and overcrowding; a doctor fortuitously intervened, leading to timely treatment.
Eight-Hour A&E Wait for Heart Attack Patient Highlights NHS Delays
68-year-old Steven Richardson endured an eight-hour wait at Worcestershire Royal Hospital's A&E department after a heart attack on November 30th, due to ambulance handover delays and overcrowding; a doctor fortuitously intervened, leading to timely treatment.
Progress
48% Bias Score
UK Pediatric Physiotherapy Delays Cause Irreversible Harm to Children
A survey of UK paediatric physiotherapists reveals unacceptable delays in accessing services, causing irreversible harm to children; some families travel over 200 miles for treatment, while others go private due to lengthy waits and staff shortages, creating a potential lifelong impact on a generati...
UK Pediatric Physiotherapy Delays Cause Irreversible Harm to Children
A survey of UK paediatric physiotherapists reveals unacceptable delays in accessing services, causing irreversible harm to children; some families travel over 200 miles for treatment, while others go private due to lengthy waits and staff shortages, creating a potential lifelong impact on a generati...
Progress
56% Bias Score
NHS to Offer £1.65m Gene Therapy for Sickle Cell Disease
England's NHS will offer the £1.65m gene-editing therapy Casgevy to about 50 sickle cell patients yearly, marking a major advance in treating this life-threatening blood disorder primarily affecting people of Black African and Black Caribbean heritage, offering a potential cure and improved quality ...
NHS to Offer £1.65m Gene Therapy for Sickle Cell Disease
England's NHS will offer the £1.65m gene-editing therapy Casgevy to about 50 sickle cell patients yearly, marking a major advance in treating this life-threatening blood disorder primarily affecting people of Black African and Black Caribbean heritage, offering a potential cure and improved quality ...
Progress
44% Bias Score
UK Healthtech Unicorn Cera Care Secures \$150M, Saves NHS \$1M Daily
Cera Care, a UK healthtech unicorn, secured \$150 million in funding to expand its AI-powered home care platform, saving the NHS \$1 million daily by reducing hospitalizations and improving preventative care, highlighting the potential of private-sector partnerships in addressing the UK's healthcare...
UK Healthtech Unicorn Cera Care Secures \$150M, Saves NHS \$1M Daily
Cera Care, a UK healthtech unicorn, secured \$150 million in funding to expand its AI-powered home care platform, saving the NHS \$1 million daily by reducing hospitalizations and improving preventative care, highlighting the potential of private-sector partnerships in addressing the UK's healthcare...
Progress
64% Bias Score
NICE Approves New Drug for Severe Dust Mite Allergy
NICE has approved Acarizax, a new drug for people aged 12-65 in England with persistent moderate to severe house dust mite allergic rhinitis whose symptoms are not controlled by standard treatments; approximately 13,000 people could benefit from this first-of-its-kind treatment.
NICE Approves New Drug for Severe Dust Mite Allergy
NICE has approved Acarizax, a new drug for people aged 12-65 in England with persistent moderate to severe house dust mite allergic rhinitis whose symptoms are not controlled by standard treatments; approximately 13,000 people could benefit from this first-of-its-kind treatment.
Progress
48% Bias Score
Showing 85 to 96 of 213 results